FOLD icon

Amicus Therapeutics

257 hedge funds and large institutions have $2.74B invested in Amicus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 96 increasing their positions, 77 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

17% less first-time investments, than exits

New positions opened: 52 | Existing positions closed: 63

58% less capital invested

Capital invested by funds: $6.44B → $2.74B (-$3.71B)

Holders
257
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$26.6M
Puts
$21.6M
Net Calls
Net Calls Change

Top Sellers

1 -$154M
2 -$31.2M
3 -$31.1M
4
Morgan Stanley
Morgan Stanley
New York
-$27.3M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$26.3M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$1.34M
102
$1.24M
103
$1.18M
104
$1.15M
105
$1.13M
106
$1.12M
107
$1.09M
108
$1.04M
109
$1.02M
110
$988K
111
$970K
112
$946K
113
$935K
114
$935K
115
$917K
116
$902K
117
$878K
118
$877K
119
$825K
120
$810K
121
$806K
122
$788K
123
$778K
124
$759K
125
$696K